Scoop has an Ethical Paywall
Cancer detection commercialisation can't be 'overnight'
Cancer detection commercialisation could never be an 'overnight' happening
By Peter Kerr for sticK
(sticK - 30 Nov. 2010 ) Pacific Edge Ltd., is inching its way to commercialisation of its bladder cancer detection tests - showing that it can be done, but never 'overnight'.
Above all it also demonstrates just how much effort it takes to turn an idea, detecting the presence of cancer cells in urine, and turning that into a sellable product - an assay test that is easily and accurately able to be used by urologists and physicians as a diagnostic and prognosis tool.
Along the way the Dunedin-based company has had to prove its methodology in different locations; so far in Australasia, America and Europe, and is now working on the best way to commercially roll out the tests.
For sticK – science, technology, innovation &
commercialisation KNOWLEDGE - is a new Wellington based
news service concentrating on following the money from ideas
to income. Contact editor Peter Kerr at peter.kerr055 @
gmail.com
Peter Kerr
Message maker
Writer, communicator, simplifier, storyteller.
Versed in the art and science of translating something complicated into an understandable message.
NZAS: New Zealand Association Of Scientists Awards Celebrate The Achievements Of Scientists And Our Science System
Stats NZ: Retail Spending Flat In The September 2024 Quarter
Antarctica New Zealand: International Team Launch Second Attempt To Drill Deep For Antarctic Climate Clues
Vegetables New Zealand: Asparagus Season In Full Flight: Get It While You Still Can 
Bill Bennett: Download Weekly - How would NZ telecoms cope with another cyclone
NZ On Air: Firm Audience Favourites Lead NZ On Air Non-Fiction Funding
